SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 6

Serum Prolidase Activity in Cardiovascular Disease

Lütfü AŞKIN
Okan TANRIVERDİ
Pages
537–540
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed to present a review to show the role of SPA based on cardiovascular diseases and how it will contribute to prognosis with the most recent data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serum prolidase activity (SPA) plays a vital role in plaque stabilization in collagen turnover in atherosclerotic plaques.
📊
Key Findings & Data:Thus, SPA has an essential role in the diagnosis and prevention of coronary artery disease.
💡
Conclusion & Impact:We aimed to present a review to show the role of SPA based on cardiovascular diseases and how it will contribute to prognosis with the most recent data.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serum prolidase activity (SPA) plays a vital role in plaque stabilization in collagen turnover in atherosclerotic plaques. Thus, SPA has an essential role in the diagnosis and prevention of coronary artery disease. SPA values may be higher in hypertension, atrial fibrillation, coronary artery ectasia, and aneurysmatic diseases than average values due to collagen turnover and oxidative stress. We aimed to present a review to show the role of SPA based on cardiovascular diseases and how it will contribute to prognosis with the most recent data.

🔖

Cite This Article

AŞKIN, L., TANRIVERDİ, O. (2022). Serum Prolidase Activity in Cardiovascular Disease. Erciyes Medical Journal, Cilt: 43 - Sayı: 6, 537–540. https://ajindex.com/articles/502219

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Aciksari G, Demir B, Uygun T, Gedikbasi A, Kutlu O, Atici A, et al. Serum prolidase activity in patients with cardiac syndrome X. North Clin Istanb 2020; 7(5): 471–7
  2. Misiura M, Miltyk W. Current understanding of the emerging role of prolidase in cellular metabolism. Int J Mol Sci 2020; 21(16): 5906
  3. Gunbatar H, Kaplan HS, Yildiz S. Is there a correlation between obstructive sleep-apnea syndrome severity and prolidase activity as an oxidative stress marker?. Niger J Clin Pract 2020; 23(2): 252–7
  4. Aktürk E, Aşkın L, Nacar H, Taşolar MH, Türkmen S, Çetin M, et al. Association of serum prolidase activity in patients with isolated coronary artery ectasia. Anatol J Cardiol 2018; 19(2): 110–6
  5. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012; 125(1): 188–97
  6. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, et al. Atherosclerotic plaque stability--what determines the fate of a plaque? Prog Cardiovasc Dis 2008; 51(3): 183–94
  7. Fan D, Takawale A, Basu R, Patel V, Lee J, Kandalam V, et al. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovasc Res 2014; 103(2): 268–80
  8. Lenglet S, Mach F, Montecucco F. Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm 2013; 2013: 659282
  9. Sultan A, Zheng Y, Trainor PJ, Siow Y, Amraotkar AR, Hill BG, et al. Circulating prolidase activity in patients with myocardial infarction. Front Cardiovasc Med 2017; 4: 50
  10. Demirtas S, Karahan O, Yazıcı S, Guclu O, Calıskan A, Tezcan O, et al. Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia-reperfusion injury. Kaohsiung J Med Sci 2015; 31(3): 115–22
  11. Szoka L, Karna E, Morka RP, Palka JA. Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2015; 388(6): 677– 83
  12. Erkus E, Altiparmak H, Sezen H, Kaya Z, Gunebakmaz O, Sezen Y, et al. Serum prolidase activity in patients with left ventricular diastolic dysfunction. Acta Cardiol 2015; 70(1): 51–7
  13. Wachtell K, Bella JN, Rokkedal J, Palmieri V, Papademetriou V, Dahlöf B, et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For En